Skip to main content
. 2017 Jan 23;8(3):321–326. doi: 10.1021/acsmedchemlett.6b00491

Table 5. In Vitro CYP Inhibition with 36.

Enzyme Substrate Control Inhibitor (IC50 (μM)) Cmpd 36 IC50 (μM)
CYP1A2 Phenacetin Furafylline (6.29) 58.6
CYP2C8 Paclitaxel Quercetin (1.20) 7.9
CYP2C9 Tolbutamide Sulfaphenazole (0.205) 8.5
CYP2C19 S-Mephentoin Tranylcypromine (10.3) 20.0
CYP2D6 Bufuralol Quinidine (0.035) 148
CYP3A4 Midazolam Ketoconazole (0.018) 81.9
CYP3A4 Testosterone Ketoconazole (0.015) 12.5